Meckler Jeffrey A

Average Profitability
21.7%
Insider Buys Quantity
14
Insider Buys Sum
$1.37M
Insider Sells Quantity
1
Insider Sells Sum
$562,324.00

Insider Activity of Meckler Jeffrey A

According to the SEC Form 4 filings, Meckler Jeffrey A, being in a position of

  1. director at Travere Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 40000 shares for $562,324,
    over all time since 2014-11-25, has bought 60000 shares for $700,228, and sold 40000 shares for $562,324.

The largest purchase of all time was on 2016-03-03 and amounted to 20000 shares of Travere Therapeutics, Inc. for $289,000.

The largest sale of all time was on 2024-09-30 and amounted to 40000 shares of Travere Therapeutics, Inc. for $562,324.

Biography of Meckler Jeffrey A

No biography is available at this moment.

2024-09-30SaleTravere Therapeutics, Inc.
TVTX
director
40,000
0.0489%
$14.06$562,324+25.34%
2022-11-21PurchaseIndaptus Therapeutics, Inc.
INDP
CEO and Director
9,600
0.122%
$1.90$18,240+5.25%
2022-11-18PurchaseIndaptus Therapeutics, Inc.
INDP
CEO and Director
400
0.0047%
$1.76$705+4.97%
2022-09-08PurchaseIndaptus Therapeutics, Inc.
INDP
CEO and Director
10,308
0.1329%
$2.80$28,862-29.85%
2022-09-06PurchaseIndaptus Therapeutics, Inc.
INDP
CEO and Director
8,632
0.1092%
$2.57$22,184-25%
2022-06-06PurchaseIndaptus Therapeutics, Inc.
INDP
CEO and Director
19,727
0.2371%
$2.63$51,882-28.68%
2021-11-18PurchaseIndaptus Therapeutics, Inc.
INDP
CEO and Director
11,187
0.2847%
$5.82$65,108-44.81%
2021-09-14PurchaseIndaptus Therapeutics, Inc.
INDP
CEO and Director
12,000
0.2842%
$7.00$84,000-43.28%
2016-03-15PurchaseCocrystal Pharma, Inc.
COCP
294,118
0.0353%
$0.51$150,000-22.95%
2016-03-04PurchaseTravere Therapeutics, Inc.
TVTX
director
10,000
0.0282%
$15.31$153,129+24.34%
2016-03-03PurchaseTravere Therapeutics, Inc.
TVTX
director
20,000
0.0545%
$14.45$289,000+27.31%
2015-12-23PurchaseCocrystal Pharma, Inc.
COCP
100,000
0.0151%
$0.58$57,870-3.64%
2015-03-25PurchaseCocrystal Pharma, Inc.
COCP
163,043
0.0216%
$0.92$150,000-22.77%
2014-12-11PurchaseCocrystal Pharma, Inc.
COCP
200,000
0.0151%
$0.23$45,610+88.64%
2014-11-25PurchaseTravere Therapeutics, Inc.
TVTX
director
30,000
0.1058%
$8.60$258,099+147.72%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.